tykhr
sign in
free sign up
Ligand Pharmaceuticals Incorporated
Biotechnology
Healthcare
LGND
19.19 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
171.03
52 week high
170.77
high
172.30
52 week low
0.00
low
169.81
growth
66.00 %
previous Close
170.77
P/E ratio
market cap
2.56 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
93.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top